You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: December 23, 2024

Details for Patent: 8,722,702


✉ Email this page to a colleague

« Back to Dashboard


Which drugs does patent 8,722,702 protect, and when does it expire?

Patent 8,722,702 protects TURALIO and is included in one NDA.

This patent has forty-eight patent family members in thirty-five countries.

Summary for Patent: 8,722,702
Title:Compounds modulating c-fms and/or c-kit activity and uses therefor
Abstract: Compounds active on the receptor protein tyrosine kinases c-kit and/or c-fms are provided herewith. Also provided herewith are compositions useful for treatment of c-kit mediated diseases or conditions and/or c-fms-mediated diseases or conditions, and methods for the use thereof.
Inventor(s): Zhang; Jiazhong (Burlingame, CA), Ibrahim; Prabha N. (Mountain View, CA), Artis; Dean R. (Kensington, CA), Bremer; Ryan (Emeryville, CA), Wu; Guoxian (Foster City, CA), Nespi; Marika (Berkeley, CA), Zhang; Chao (Moraga, CA)
Assignee: Plexxikon Inc. (Berkeley, CA)
Application Number:13/776,547
Patent Claim Types:
see list of patent claims
Composition; Compound;
Patent landscape, scope, and claims:

Understanding the Scope and Claims of United States Patent 8,722,702: A Comprehensive Analysis

Introduction

Patent 8,722,702, like any other patent, is a complex document that outlines the scope and claims of an invention. To fully comprehend its implications, it is crucial to delve into the specifics of patent law, the process of patent application, and the criteria for patentability.

Patentability Requirements

For any patent, including US Patent 8,722,702, the invention must meet several key requirements to be considered patentable. These include being useful, novel, and nonobvious, and claiming patentable subject matter[4].

Utility

The invention must be operable and provide some tangible benefit. This means the invention should have a practical application and offer a clear advantage over existing technologies[4].

Novelty

The invention must not be fully anticipated by prior patents, publications, or other state of the art knowledge. This ensures that the invention is new and not already known in the field[4].

Nonobviousness

The invention must not have been readily within the ordinary skills of a competent artisan at the time it was made. This requirement ensures that the invention is innovative and not simply an obvious extension of existing knowledge[4].

The Patent Application Process

The journey to obtaining a patent like 8,722,702 involves several steps, each critical in determining the patent's validity and scope.

Provisional Patent Application

Often, the process begins with a provisional patent application, which provides a temporary protection for one year. This allows the inventors to file a non-provisional patent application within that year[5].

Non-Provisional Patent Application

A non-provisional patent application is a more detailed and formal application that starts the national phase of the patenting process. This application is reviewed by a patent examiner to determine its patentability[5].

Patent Examination and Prosecution

During the examination process, the patent examiner reviews the application to ensure it meets all the requirements for patentability. This can involve arguments and amendments to the claims to address any issues raised by the examiner[5].

Claim Allowance and Rejections

If the claimed invention is patentable as submitted, the patent examiner will allow the claims to issue into a patent. However, if the application is not patentable as originally submitted, the examiner may issue a final rejection. In such cases, the applicant can appeal the decision to an appeal board or the U.S. court system[5].

Scope of Patent Claims

The scope of patent claims is a critical aspect of any patent, including 8,722,702. The scope defines what is protected by the patent and what constitutes infringement.

Independent Claim Length and Count

Research has shown that the length and count of independent claims can be metrics for measuring patent scope. Narrower claims are often associated with a higher probability of grant and a shorter examination process[3].

Practical Applications

To ensure the patent claims are valid, it is essential to highlight the real-world applications of the claimed method or system. Demonstrating how the abstract idea is applied in a way that provides concrete benefits or solves specific problems in the relevant field is crucial[1].

AI and Patent Eligibility

In the context of AI-related inventions, the recent USPTO guidance update provides significant insights. The update clarifies that the method of invention development, including the use of AI, does not impact subject matter eligibility. Instead, the focus remains on the claimed invention itself, ensuring that AI-assisted inventions are evaluated on equal footing with other technologies[1].

Examples and Case Law

The USPTO has introduced new examples specifically tailored to AI technologies, illustrating how claims involving AI can meet the eligibility criteria. For instance, Example 48 shows how specifying the use of separated audio components in a real-time speech recognition system can transform an abstract idea into a patent-eligible invention by providing a practical application[1].

Determining Inventorship

Correctly determining who should be listed as an inventor is a critical but often underemphasized aspect of patent law. In the United States, invention is a two-step process: conception of the idea and reduction of the idea to practice. Only those who contribute to these steps should be listed as inventors[2].

Cost and Commercial Considerations

The process of obtaining and maintaining a patent is costly. Drafting and filing a non-provisional patent application can cost between $8,000 and $20,000, with additional costs incurred during the patent prosecution process. International patents can be even more expensive[5].

Key Takeaways

  • Patentability Requirements: The invention must be useful, novel, and nonobvious, and claim patentable subject matter.
  • Patent Application Process: The process involves provisional and non-provisional applications, with a detailed examination by a patent examiner.
  • Scope of Claims: The scope is defined by the independent claims, which should be narrow and practical to ensure validity.
  • AI and Patent Eligibility: AI-assisted inventions are evaluated based on the claimed invention itself, with a focus on practical applications.
  • Determining Inventorship: Only those who contribute to the conception and reduction to practice should be listed as inventors.
  • Cost and Commercial Considerations: The patenting process is costly, with significant expenses for drafting, filing, and maintaining patents.

FAQs

Q: What are the key requirements for a patent to be considered patentable?

A: The invention must be useful, novel, and nonobvious, and claim patentable subject matter.

Q: How does the use of AI impact the patent eligibility of an invention?

A: The use of AI in the method of invention development does not impact subject matter eligibility. The focus remains on the claimed invention itself, ensuring AI-assisted inventions are evaluated equally with other technologies[1].

Q: What is the significance of independent claim length and count in patent scope?

A: Narrower claims are associated with a higher probability of grant and a shorter examination process. These metrics can help measure patent scope and ensure the claims are valid[3].

Q: Why is determining inventorship important in patent applications?

A: Correctly determining who should be listed as an inventor is crucial as it ensures that only those who contribute to the conception and reduction to practice are recognized as inventors[2].

Q: What are the typical costs associated with obtaining and maintaining a patent?

A: The costs can range from $8,000 to $20,000 for drafting and filing a non-provisional patent application, with additional costs during the patent prosecution process. International patents can be even more expensive[5].

Sources

  1. Understanding the 2024 USPTO Guidance Update on AI Patent - Mintz
  2. Determining Inventorship for US Patent Applications - Oregon State University
  3. Patent Claims and Patent Scope - SSRN
  4. Patents and Innovation Policy - CRS Reports
  5. Intellectual Property Protection - KU Office of Research

More… ↓

⤷  Subscribe


Drugs Protected by US Patent 8,722,702

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Submissiondate
Daiichi Sankyo Inc TURALIO pexidartinib hydrochloride CAPSULE;ORAL 211810-002 Oct 14, 2022 RX Yes No 8,722,702 ⤷  Subscribe Y ⤷  Subscribe
Daiichi Sankyo Inc TURALIO pexidartinib hydrochloride CAPSULE;ORAL 211810-001 Aug 2, 2019 DISCN Yes No 8,722,702 ⤷  Subscribe Y ⤷  Subscribe
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Patented / Exclusive Use >Submissiondate

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.